FDA withdraws proposed rule on generic label changes
How Big Pharma decides to kill R&D programs
Government shutdown could hobble FDA
JNJ willing to pay more than $400m to settle Pinnacle Hip cases
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*